Product
99mTc-NM-02
Aliases
anti-HER2 SPECT/CT radiotracer, Injection of 99mTc-NM-02
2 clinical trials
2 indications
Indication
Breast CancerIndication
RadiotoxicityClinical trial
Technetium-99m Labeled Anti-HER2 sdAb (99m-Tc-NM-02) for HER2 Expression Detection in Breast CancerStatus: Completed, Estimated PCD: 2021-12-31
Clinical trial
Technetium-99m/Rhenium-188 Labeled Anti-HER2 Single Domain Antibody (99mTc/188Re-NM-02) for HER2 Expression Detection and Radionuclide Therapy in Breast CancerStatus: Recruiting, Estimated PCD: 2024-03-08